Skip to main content

Molecular characterisation and evaluation of neutral sphingomyelinase 2 as a novel target in multiple myeloma

Funding or Partner Organisation: Cancer Australia (Priority-driven Collaborative Cancer Research Scheme)

Start year: 2013

FOR Codes: Molecular Targets, Cancer and Related Disorders, Clinical health